Author: Jasmine Riviere Marcelin, MD

Antimicrobial Stewardship Program Takes Patient Safety Personally

At Nebraska Medicine, our Antimicrobial Stewardship Program’s (ASP) clinical mission is to optimize the utilization of antimicrobial agents, thereby improving patient outcomes (by reducing the risk of adverse events and Clostridium difficile infection) and limiting the spread of antimicrobial resistance.   These Antimicrobial Stewardship activities have been mandated by the Joint Commission and our program has […]

Mar 14, 2018

Happy International Women’s Day! Meet the Women Faculty of UNMC ID

March 8, International Women’s Day, was created as a day to recognize the women’s rights movements around the world. This year’s theme is #PressforProgress, fueled by ongoing global activism and advocacy for women’s rights in all facets of life. In an age where more women than men are enrolled in US medical schools, and 52% of […]

Mar 8, 2018

New Staff Spotlight – Danny Schroeder, PharmD

Tell us about the position you are starting:  I have recently started my role at Nebraska Medicine Bellevue as an Antimicrobial Stewardship pharmacist. I reach out to physicians at Nebraska Medicine Bellevue to discuss antibiotic therapy and try to obtain the best and safest therapy for our patients here. In addition, I work with Dr. Jasmine […]

Mar 7, 2018

CROI 2018 – The Official UNMC ID Guide of Where We Will Be!

CROI 2018 is here and we want to be sure YOU know where to find us in Boston. Below is the list of faculty presentations and posters from our Division. Come visit us at CROI – We would LOVE to meet you! Find us on Twitter @UNMC_ID ; #UNMCID Content courtesy of Kim Scarsi, Sue Swindells […]

Mar 5, 2018

Stewardship-driven Ertapenem Restriction: Can Reduced Utilization Affect the Antibiogram?

In this article review we learn about the impact of a large-scale, multi-institutional Antimicrobial Stewardship Intervention on significantly reducing the overall use of ertapenem without subsequent downstream effect on carbapenem-resistant Enterobacteriaceae (CRE) non-susceptibility patterns. Delgado A, Gawrys GW, Duhon BM, Lee GC (2017). Impact of an Antimicrobial Stewardship Initiative on Ertapenem Use and Carbapenem Susceptibilities […]

Mar 1, 2018

Pharm to Exam Table – Trimethroprim/Sulfamethoxazole for Nocardiosis

Pharm to Exam Table: Clinical Pharmacology/Antibiotic Updates – Trimethroprim/Sulfamethoxazole for Nocardiosis Nocardia is an aerobic, gram-positive bacterium commonly found in soil, decomposing vegetation, fresh water, and salt water. Nocardia is typically considered an opportunistic pathogen, but there have been several cases of nocardiosis occurring in immunocompetent hosts. Patients that are most at risk of developing nocardiosis are those with […]

Feb 26, 2018

Honoring Black Women and Men Physician Leaders in Infectious Diseases

African Americans account for only 6% of newly minted doctors graduating from medical school in the USA. Within our specialty of Infectious Diseases, only 3% of ID physician members of the Infectious Diseases Society of America (IDSA) self-report as Black/African American. Many of these physicians make it their career goals to provide care for and […]

Feb 22, 2018

Reflections on a year of blogging

On February 14, 2017, led by our Division’s own Social Media Maven Dr. Kelly Cawcutt, we launched our UNMC Infectious Diseases Blog with a welcome post. 365 days, 134 posts, and almost 14,000 views later, we are still here! We have introduced our faculty, shared thoughts on why ID is special to us, recruited for […]

Feb 14, 2018

Calamities of Kissing – Happy Valentine’s Day from UNMC ID

It’s almost Valentine’s day, and in honor of the one day of the year commercially dedicated to L’Amour, we thought would be fun to talk about some of the Infectious Diseases associated with “kissing”. Let’s start with “The Kissing Disease” – Infectious Mononucleosis: Infectious Mononucleosis or “Mono” is an illness most commonly caused by a […]

Feb 12, 2018

Plazomicin: Will it be the future of MDRO treatment?

Today at our UNMC Infectious Disease Research Conference, Dr. Kelly Cawcutt’s presentation included details on Plazomicin, a new antibiotic recently granted FDA Breakthrough Therapy Designation,  aimed at treating multi-drug resistant organisms (MDROs). Antibiotic resistance continues to be a clinical problem. The CDC Antibiotic Threat Report has estimated 2 million infections with antibiotic resistant organisms and […]

Feb 6, 2018